Is there clinical utility to IL28B genotype testing in the treatment of chronic hepatitis C virus infection?
The miRNA–drug resistance connection: a new era of personalized medicine using noncoding RNA begins
News & Views in … Pharmacogenomics
Potential targeted treatment for non-small-cell lung cancer suggested by Phase II trial
Innovative pharmacogenomics test for pain management introduced by Millennium Laboratories
The potential of dabrafenib to treat BRAF-positive melanoma: results from a recent Phase III trial
Web-based genomic and pharmacologic tools facilitate matching cancer drugs with gene targets
Research Highlights: Highlights from the latest articles in pharmacogenomics of oral antidiabetic drugs
KCNQ1 variants and response to repaglinide treatment in patients with Type 2 diabetes
Pharmacogenetic differences among insulin secretagogues based on KCNJ11/ABCC8 haplotypes
Replication of the association of gene variant near ATM and response to metformin
Institutional Profile: Pharmacogenomics research at Newcastle University
Effects of polymorphisms in six candidate genes on phenytoin maintenance therapy in Han Chinese patients
Effects of mitotane on gene expression in the adrenocortical cell line NCI-H295R: a microarray study
G894T polymorphism of eNOS gene is a predictor of response to combination of inhaled corticosteroids with long-lasting β2-agonists in asthmatic children
Epigenetic-dependent regulation of drug transport and metabolism: an update
Integrative systems biology approaches in asthma pharmacogenomics
Cost–effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs
The current and future state of pharmacogenomics medical education in the USA
Association of DHODH haplotype variants and response to leflunomide treatment in rheumatoid arthritis
Acknowledgements